{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T18:42:50Z","timestamp":1795200170033,"version":"4.10.3"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["U54CK000611"],"award-info":[{"award-number":["U54CK000611"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["K08HS029518"],"award-info":[{"award-number":["K08HS029518"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000098","name":"National Institutes of Health Clinical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Little is known about the frequency, hospital-level variation, predictors, and outcomes of antibiotic de-escalation in suspected sepsis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We retrospectively analyzed adults admitted to 236 US hospitals from 2017\u20132021 with suspected sepsis (defined by blood culture draw, lactate measurement, and intravenous antibiotic administration) who were initially treated with \u22652 days of anti\u2013methicillin-resistant Staphylococcus aureus (MRSA) and anti-pseudomonal antibiotics but had no resistant organisms that required these agents identified through hospital day 4. De-escalation was defined as stopping anti-MRSA and anti-pseudomonal antibiotics or switching to narrower antibiotics by day 4. We created a propensity score for de-escalation using 82 hospital and clinical variables; matched de-escalated to non\u2013de-escalated patients; and assessed associations between de-escalation and outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among 124 577 patients, antibiotics were de-escalated in 36 806 (29.5%): narrowing in 27 177 (21.8%), cessation in 9629 (7.7%). De-escalation rates varied between hospitals (median, 29.4%; interquartile range, 21.3%\u201338.0%). Predictors of de-escalation included less severe disease on day 3\u20134, positive cultures for nonresistant organisms, and negative\/absent MRSA nasal swabs. De-escalation was more common in medium, large, and teaching hospitals in the Northeast and Midwest. De-escalation was associated with lower adjusted risks for acute kidney injury (AKI) (odds ratio [OR], 0.80; 95% confidence interval [CI], .76\u2013.84), intensive-care unit (ICU) admission after day 4 (OR, 0.59; 95% CI, .52\u2013.66), and in-hospital mortality (OR, 0.92; 95% CI, .86\u2013.996).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Antibiotic de-escalation in suspected sepsis is infrequent, variable across hospitals, linked with clinical and microbiologic factors, and associated with lower risk for AKI, ICU admission, and in-hospital mortality.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciae591","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T21:36:08Z","timestamp":1733866568000},"page":"108-117","source":"Crossref","is-referenced-by-count":32,"title":["Epidemiology and Outcomes of Antibiotic De-escalation in Patients With Suspected Sepsis in US Hospitals"],"prefix":"10.1093","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2402-7262","authenticated-orcid":false,"given":"Kai Qian","family":"Kam","sequence":"first","affiliation":[{"name":"Department of Population Medicine, Harvard Pilgrim Health Care Institute , Boston, Massachusetts ,","place":["USA"]},{"name":"Infectious Disease Service, Department of Pediatrics, KK Women's & Children's Hospital , Singapore City ,","place":["Singapore"]},{"name":"SingHealth Duke\u2013NUS Pediatrics Academic Clinical Program, Duke\u2013NUS Medical School , Singapore City ,","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Pilgrim Health Care Institute , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4420-9004","authenticated-orcid":false,"given":"Sameer S","family":"Kadri","sequence":"additional","affiliation":[{"name":"Critical Care Medicine Department, National Institutes of Health Clinical Center , Bethesda, Maryland ,","place":["USA"]},{"name":"Critical Care Medicine Branch, National Heart Lung and Blood Institute , Bethesda, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7948-3161","authenticated-orcid":false,"given":"Alexander","family":"Lawandi","sequence":"additional","affiliation":[{"name":"Critical Care Medicine Department, National Institutes of Health Clinical Center , Bethesda, Maryland ,","place":["USA"]},{"name":"Division of Infectious Diseases, Department of Medicine, McGill University Health Centre , Montreal, Quebec ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8293-3901","authenticated-orcid":false,"given":"Christina","family":"Yek","sequence":"additional","affiliation":[{"name":"Critical Care Medicine Department, National Institutes of Health Clinical Center , Bethesda, Maryland ,","place":["USA"]},{"name":"Critical Care Medicine Branch, National Heart Lung and Blood Institute , Bethesda, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Walker","sequence":"additional","affiliation":[{"name":"Critical Care Medicine Department, National Institutes of Health Clinical Center , Bethesda, Maryland ,","place":["USA"]},{"name":"Critical Care Medicine Branch, National Heart Lung and Blood Institute , Bethesda, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Warner","sequence":"additional","affiliation":[{"name":"Critical Care Medicine Department, National Institutes of Health Clinical Center , Bethesda, Maryland ,","place":["USA"]},{"name":"Critical Care Medicine Branch, National Heart Lung and Blood Institute , Bethesda, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Fram","sequence":"additional","affiliation":[{"name":"Commonwealth Informatics , Waltham, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huai-Chun","family":"Chen","sequence":"additional","affiliation":[{"name":"Commonwealth Informatics , Waltham, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8316-1496","authenticated-orcid":false,"given":"Claire N","family":"Shappell","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"DelloStritto","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Pilgrim Health Care Institute , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Pilgrim Health Care Institute , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8641-4498","authenticated-orcid":false,"given":"Michael","family":"Klompas","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Pilgrim Health Care Institute , Boston, Massachusetts ,","place":["USA"]},{"name":"Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9537-4245","authenticated-orcid":false,"given":"Chanu","family":"Rhee","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Pilgrim Health Care Institute , Boston, Massachusetts ,","place":["USA"]},{"name":"Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital , Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"key":"2025020710481761300_ciae591-B1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"2025020710481761300_ciae591-B2","doi-asserted-by":"crossref","first-page":"e187571","DOI":"10.1001\/jamanetworkopen.2018.7571","article-title":"Prevalence, underlying causes, and preventability of sepsis-associated mortality in US acute care hospitals","volume":"2","author":"Rhee","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2025020710481761300_ciae591-B3","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"2025020710481761300_ciae591-B4","doi-asserted-by":"crossref","first-page":"e1224","DOI":"10.1093\/cid\/ciac504","article-title":"Patterns, predictors, and intercenter variability in empiric gram-negative antibiotic use across 928 United States hospitals","volume":"76","author":"Goodman","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2025020710481761300_ciae591-B5","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/01.CCM.0000050298.59549.4A","article-title":"Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome","volume":"31","author":"Leone","year":"2003","journal-title":"Crit Care Med"},{"key":"2025020710481761300_ciae591-B6","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1097\/CCM.0b013e3182416ecf","article-title":"Antibiotic strategies in severe nosocomial sepsis: why do we not de-escalate more often?","volume":"40","author":"Heenen","year":"2012","journal-title":"Crit Care Med"},{"key":"2025020710481761300_ciae591-B7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/QCO.0000000000000141","article-title":"Antibiotic de-escalation in the ICU: how is it best done?","volume":"28","author":"Garnacho-Montero","year":"2015","journal-title":"Curr Opin Infect Dis"},{"key":"2025020710481761300_ciae591-B8","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1186\/s12879-016-2080-3","article-title":"Frequency of empiric antibiotic de-escalation in an acute care hospital with an established antimicrobial stewardship program","volume":"16","author":"Liu","year":"2016","journal-title":"BMC Infect Dis"},{"key":"2025020710481761300_ciae591-B9","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1007\/s00134-020-06111-5","article-title":"Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study","volume":"46","author":"De Bus","year":"2020","journal-title":"Intensive Care Med"},{"key":"2025020710481761300_ciae591-B10","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.hrtlng.2016.06.001","article-title":"De-escalation of empiric antibiotics in patients with severe sepsis or septic shock: a meta-analysis","volume":"45","author":"Guo","year":"2016","journal-title":"Heart Lung"},{"key":"2025020710481761300_ciae591-B11","first-page":"CD007934","article-title":"De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock","volume":"2013","author":"Silva","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2025020710481761300_ciae591-B12","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cmi.2016.05.023","article-title":"Antibiotic de-escalation for bloodstream infections and pneumonia: systematic review and meta-analysis","volume":"22","author":"Paul","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"2025020710481761300_ciae591-B13","author":"Premier Homepage"},{"key":"2025020710481761300_ciae591-B14","doi-asserted-by":"crossref","first-page":"e2418923","DOI":"10.1001\/jamanetworkopen.2024.18923","article-title":"Trends in empiric broad-spectrum antibiotic use for suspected community-onset sepsis in US hospitals","volume":"7","author":"Rhee","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2025020710481761300_ciae591-B15","doi-asserted-by":"publisher","first-page":"ciad428","DOI":"10.1093\/cid\/ciad428","article-title":"Infectious Diseases Society of America 2023 guidance on the treatment of antimicrobial resistant gram-negative infections","author":"Tamma","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2025020710481761300_ciae591-B16","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.clinthera.2016.01.001","article-title":"Impact of an antimicrobial stewardship program on patient safety in veterans prescribed vancomycin","volume":"38","author":"Fodero","year":"2016","journal-title":"Clin Ther"},{"key":"2025020710481761300_ciae591-B17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2146\/ajhp080434","article-title":"Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists","volume":"66","author":"Rybak","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"2025020710481761300_ciae591-B18","doi-asserted-by":"crossref","first-page":"e202899","DOI":"10.1001\/jamanetworkopen.2020.2899","article-title":"Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use","volume":"3","author":"Rhee","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2025020710481761300_ciae591-B19","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1017\/pan.2020.32","article-title":"Generalized full matching","volume":"29","author":"S\u00e4vje","year":"2021","journal-title":"Polit Anal"},{"key":"2025020710481761300_ciae591-B20","doi-asserted-by":"crossref","DOI":"10.1201\/9780429492259","volume-title":"Flexible imputation of missing data. 2nd ed.","author":"van Buuren","year":"2018"},{"key":"2025020710481761300_ciae591-B21","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/cid\/ciaa212","article-title":"De-escalation of empiric antibiotics following negative cultures in hospitalized patients with pneumonia: rates and outcomes","volume":"72","author":"Deshpande","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025020710481761300_ciae591-B22","doi-asserted-by":"crossref","first-page":"ofad286","DOI":"10.1093\/ofid\/ofad286","article-title":"Early discontinuation of antibiotics in patients admitted with clinically suspected serious infection but negative cultures: retrospective cohort study of practice patterns and outcomes at 111 US hospitals","volume":"10","author":"Kadri","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2025020710481761300_ciae591-B23","doi-asserted-by":"crossref","first-page":"R225","DOI":"10.1186\/cc9373","article-title":"De-escalation as part of a global strategy of empiric antibiotherapy management. A retrospective study in a medico-surgical intensive care unit","volume":"14","author":"Morel","year":"2010","journal-title":"Crit Care"},{"key":"2025020710481761300_ciae591-B24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00134-013-3077-7","article-title":"De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock","volume":"40","author":"Garnacho-Montero","year":"2014","journal-title":"Intensive Care Med"},{"key":"2025020710481761300_ciae591-B25","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/1471-2334-14-272","article-title":"Bloodstream infections and sepsis in Greece: over-time change of epidemiology and impact of de-escalation on final outcome","volume":"14","author":"Koupetori","year":"2014","journal-title":"BMC Infect Dis"},{"key":"2025020710481761300_ciae591-B26","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/cc11197","article-title":"Early use of imipenem\/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial","volume":"16","author":"Kim","year":"2012","journal-title":"Crit Care"},{"key":"2025020710481761300_ciae591-B27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13613-023-01134-9","article-title":"Antibiotic stewardship in the ICU: time to shift into overdrive","volume":"13","author":"Mokrani","year":"2023","journal-title":"Ann Intensive Care"},{"key":"2025020710481761300_ciae591-B28","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1177\/0885066618762747","article-title":"Antibiotic use in the intensive care unit: optimization and de-escalation","volume":"33","author":"Campion","year":"2018","journal-title":"J Intensive Care Med"},{"key":"2025020710481761300_ciae591-B29","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s13054-021-03787-z","article-title":"Timing of antibiotic therapy in the ICU","volume":"25","author":"Kollef","year":"2021","journal-title":"Crit Care"},{"key":"2025020710481761300_ciae591-B30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s15010-011-0116-6","article-title":"De-escalation of antimicrobials in the treatment of bacteraemia due to antibiotic-sensitive pathogens in immunocompetent patients","volume":"39","author":"Shime","year":"2011","journal-title":"Infection"},{"key":"2025020710481761300_ciae591-B31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2147\/IDR.S391295","article-title":"Impact of positive culture reports of E. coli or MSSA on de-escalation of antibiotic use in a teaching hospital in Pakistan and the implications","volume":"16","author":"Haseeb","year":"2023","journal-title":"Infect Drug Resist"},{"key":"2025020710481761300_ciae591-B32","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/cid\/ciz974","article-title":"Determining the utility of methicillin-resistant Staphylococcus aureus nares screening in antimicrobial stewardship","volume":"71","author":"Mergenhagen","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025020710481761300_ciae591-B33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/jpids\/piad111","article-title":"Predictive value of methicillin-resistant Staphylococcus aureus nasal swab PCR assay for MRSA infection in critically ill pediatric patients","volume":"13","author":"Crawford","year":"2024","journal-title":"J Pediatr Infect Dis Soc"},{"key":"2025020710481761300_ciae591-B34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00134-019-05866-w","article-title":"Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP)","volume":"46","author":"Tabah","year":"2020","journal-title":"Intensive Care Med"},{"key":"2025020710481761300_ciae591-B35","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s00134-014-3411-8","article-title":"De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial","volume":"40","author":"Leone","year":"2014","journal-title":"Intensive Care Med"},{"key":"2025020710481761300_ciae591-B36","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/cid\/ciae253","article-title":"Preventing new gram-negative resistance through beta-lactam de-escalation in hospitalized patients with sepsis: a retrospective cohort study","volume":"79","author":"Teshome","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2025020710481761300_ciae591-B37","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13054-020-02989-1","article-title":"The gut microbiome's role in the development, maintenance, and outcomes of sepsis","volume":"24","author":"Adelman","year":"2020","journal-title":"Crit Care"},{"key":"2025020710481761300_ciae591-B38","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/cid\/civ120","article-title":"Impact of infectious disease consultation on quality of care, mortality, and length of stay in Staphylococcus aureus bacteremia: results from a large multicenter cohort study","volume":"60","author":"Bai","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2025020710481761300_ciae591-B39","first-page":"855","article-title":"Association between infectious diseases consultation and mortality in hospitalized patients with gram-negative bloodstream infection: a retrospective population-wide cohort study","volume":"79","author":"Ong","year":"2024","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciae591\/60964159\/ciae591.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/80\/1\/108\/60964159\/ciae591.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/80\/1\/108\/60964159\/ciae591.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T10:48:50Z","timestamp":1738925330000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/80\/1\/108\/7917533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12,6]]},"published-print":{"date-parts":[[2025,2,5]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciae591","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1,15]]},"published":{"date-parts":[[2024,12,6]]}}}